Celltrion’s Remsima SC Biosimilar Starts Strong In EU5 Countries

New Study Follows Approval For IBD Indications Last Year

 
• By Dean Rudge
IBD
The report sampled 246 EU5 gastroenterologists in November and December last year. • Source: Shutterstock

More from Biosimilars

More from Products